TRANSPLANTATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2024-09-27 ms3000001257361917 来自浙江省

大修修回后半个月了，目前在decision，不知道啥情况/

20 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2024-05-06 reject 来自重庆

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：器官移植
经验分享：每轮审稿大概一个月大修了一次

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2024-05-18 ms2000001222319062 来自北京

审稿速度:2.0 | 投稿命中率:75.0
经验分享：1

94 0

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2019-01-09 122c9d8am23(暂无昵称)

审稿速度:1.0
经验分享：第一次投这个杂志，已online。贡献一下进度：
2018年
4.22 submit
4.23 with editor
4.25 under review
5.23 decision in process
5.29 major revision
9.6 accepted

342 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2022-12-08 还是要多读多写呀来自辽宁省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：移植
经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。

128 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2022-12-08 1dd7fa94m57(暂无匿称) 来自上海

审稿速度:1.0
偏重的研究方向：器官移植
经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待

168 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2022-12-08 还是要多读多写呀来自辽宁省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：器官移植;移植
经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。

138 0

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2022-07-05 还是要多读多写呀

偏重的研究方向：移植
经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。

166 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2022-07-19 lancet1111

偏重的研究方向：移植;肝移植
经验分享：6-21投稿，不知结果咋样

165 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2228005, encodeId=1e0722280059a, content=大修修回后半个月了，目前在decision，不知道啥情况/, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96cf5700954, createdName=ms3000001257361917, createdTime=Fri Sep 27 15:11:30 CST 2024, time=2024-09-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2202008, encodeId=9098220200801, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：器官移植 经验分享：每轮审稿大概一个月大修了一次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a3e65537446, createdName=reject, createdTime=Mon May 06 15:13:36 CST 2024, time=2024-05-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2205348, encodeId=3bf6220534801, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08738709, createdName=ms2000001222319062, createdTime=Sat May 18 11:10:08 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=565369, encodeId=894c56536983, content=审稿速度:1.0 经验分享：第一次投这个杂志，已online。贡献一下进度： 2018年 4.22 submit 4.23 with editor 4.25 under review 5.23 decision in process 5.29 major revision 9.6 accepted , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eor1jaQgJia4P7gAicygKvFF6WUhgLP1Is8HJbSLUL86dtfvxVxWmmFWUAEyweWhtX7JiaaJIgs5EPQA/132, createdBy=66582359200, createdName=122c9d8am23(暂无昵称), createdTime=Wed Jan 09 14:22:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104858, encodeId=a02e2104858f7, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:37:02 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2104977, encodeId=0d2921049e7ec, content=审稿速度:1.0 偏重的研究方向：器官移植 经验分享：2022-11-1 投稿，2022-12-3 Decision in prosess, 快5个工作日了，焦急的等待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b1d1627409, createdName=1dd7fa94m57(暂无匿称), createdTime=Thu Dec 08 20:41:22 CST 2022, time=2022-12-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2104860, encodeId=e1672104860c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：器官移植;移植 经验分享：2022.06.28投稿，期间送审两位专家，大修，补实验申请延期1个月，2022.12.07 accept.编辑很好，回复邮件非常迅速（应该是一般当天上班看到即回复），借用导师的话：老牌杂志，靠谱。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Thu Dec 08 00:40:03 CST 2022, time=2022-12-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1230788, encodeId=c4781230e8864, content=偏重的研究方向：移植 经验分享：请各位指教：6.28投稿，投稿后状态显示：Submissions Being Processed，6.29收到稿件号确认邮件。至今进入后状态一直显示：Similarity Check/iThenticate Results (29%)，我是要降重然后重新投嘛？还是等编辑回复呀，谢谢各位。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0532513107, createdName=还是要多读多写呀, createdTime=Tue Jul 05 22:16:51 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233387, encodeId=2e24123338ee5, content=偏重的研究方向：移植;肝移植 经验分享：6-21投稿，不知结果咋样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Tue Jul 19 12:41:50 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943909, encodeId=a85294390934, content=letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Feb 27 11:29:41 CST 2021, time=2021-02-27, status=1, ipAttribution=)]

2021-02-27 1e235a1cm31(暂无匿称)

letter to editor，2021-1-20投稿，几天后开始under review，2021-2-19 Decision in process，2021-2-20 Decision in process，至今状态仍为Decision in process。Decision in process已有一周了，不知是否正常？希望有投稿经验的朋友给予指导，谢谢！祈求好运！

242 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务